CAS RN: 931204-39-6
Rivaroxaban iMpurity A
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
analytical reference standard (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250519
25mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 931204-39-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
931204-39-6 / 2-[2-[4-[(5S)-5-[[(5-chlorothiophene-2-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]anilino]ethoxy]acetic acid
Standard CAS: 931204-39-6
Multi CAS: Yes
Basic Information
copy
CAS
931204-39-6 copy
Multi CAS
Yes copy
Molecular Formula
C19H20CLN3O6S copy
Molecular Weight
453.900000 copy
Exact Mass
453.076134 copy
InChI
InChI=1S/C19H20ClN3O6S/c20-16-6-5-15(30-16)18(26)22-9-14-10-23(19(27)29-14)13-3-1-12(2-4-13)21-7-8-28-11-17(24)25/h1-6,14,21H,7-11H2,(H,22,26)(H,24,25)/t14-/m0/s1 copy
InChIKey
AONZTKUREAFWOY-AWEZNQCLSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
30 copy
Aromatic heavy atom count
11 copy
Fraction Csp3
0.32 copy
Rotatable bonds
10 copy
H-bond acceptors
7 copy
H-bond donors
3 copy
Molar refractivity
112.66 copy
TPSA
117.2 copy
LogP / Solubility
WLOGP
2.67 copy
MLOGP
2.38 copy
XLogP3
2.9 copy
Consensus LogP
2.65 copy
Log S (ESOL)
-3.95 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-5.21 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-6.03 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
Yes copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.59 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy